MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Venture Capital: *Investment Round
Venture Capital: Series D
CyVek
Parents
*Architects: Biotechnology_Biomarkers
Industry: Connecticut
Venture Capital: Series D
Children
CyVek is a biotech company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for testing biomarkers and performing multi-analyte immunoassays.
CyVek's approach, The CyPlex System, is based on immunoassay design and device architecture.
Investors: Connecticur Innovations
Series D, AMT: $5.5 Million (2013)
The simplicity, power, speed and flexibility of CyVek's new platform enable researchers and clinicians to achieve major advancements in protein research and immunodiagnostics.